Michael Saylor, CEO of Strategy, suggested his company purchased more Bitcoin last week as BTC prices dipped to around $62,000, marking a 17% drop over the past month. Despite the losses, Strategy holds a significant Bitcoin treasury but faces exclusion from MSCI indexes due to its classification as a non-operating company. Similarly, Strive's CEO also hinted at increased Bitcoin purchases, reflecting confidence in accumulating BTC during the dip. These moves highlight ongoing institutional interest in Bitcoin despite recent market volatility.
Michael Saylor's Bitcoin buying strategy is the subject, with Pluang market data providing context for cryptocurrency trends. For readers following major cryptocurrencies on Pluang as of Nov 15, 2026 22:41 WIB, only 8 of 50 major cryptocurrencies rose while 41 fell. Among notable movers, Balancer (BAL) increased by 11.14% to Rp16,297, contrasting with Zilliqa (ZIL) which dropped 13.23% to Rp22, and Filecoin (FIL) which declined 8.65% to Rp11,126. Typical hold times vary from 85 days for BAL to 135 days for ZIL, with order activity showing a strong sell bias for ZIL at 77% sell versus 23% buy.
Viking Therapeutics reported that 74% of participants receiving weekly subcutaneous VK2735 improved by at least one BMI category after 13 weeks, with no patients experiencing BMI worsening. The Phase 2 VENTURE trial also showed significant improvemen...
In Q3 2026, AMG TimesSquare Small Cap Growth Fund outperformed the Russell 2000® Growth Index, driven by strong holdings in Information Technology, Financials, and Consumer Staples sectors. The fund's success was attributed to company-specific fundam...
The Schwab US Dividend Equity ETF (SCHD) has rallied about 10% since early October, supported by stronger earnings from key holdings like Texas Instruments and UnitedHealth, as well as inflows into dividend-focused funds. SCHD trades at roughly 18.6 ...
Helus Pharma will present topline results from its Phase 3 APPROACH study evaluating HLP003 as an adjunctive treatment for major depressive disorder on November 16, 2026. This drug has received Breakthrough Therapy Designation from the FDA, highlight...
Eaton Vance Tax-Advantaged Global Dividend Income Fund (ETG) raised its monthly distribution by 23.7%, marking its highest payout since inception. Despite this increase and strong long-term returns, ETG shares trade at a significant discount of over ...
